Skip to main content
EnglishEN

Commercial feasibility of targeting the histone methyltransferase SETD8 in cancer: New chemical entities and biomarkers.

Project description

DEENESFRITPL

Clinical development of SETD8 inhibitors

Fields of science

Programme(s)

Topic(s)

Call for proposal

ERC-2020-PoC

See other projects for this call

Funding Scheme

ERC-POC-LS - ERC Proof of Concept Lump Sum Pilot

Host institution

FUNDACION SECTOR PUBLICO ESTATAL CENTRO NACIONAL INVESTIGACIONES ONCOLOGICAS CARLOS III
Net EU contribution
€ 150 000,00
Address
C Melchor Fernandez Almagro 3
28029 Madrid
Spain

See on map

Region
Comunidad de Madrid Comunidad de Madrid Madrid
Activity type
Research Organisations
Non-EU contribution
No data

Beneficiaries (1)

FUNDACION SECTOR PUBLICO ESTATAL CENTRO NACIONAL INVESTIGACIONES ONCOLOGICAS CARLOS III
Spain
Net EU contribution
€ 150 000,00
Address
C Melchor Fernandez Almagro 3
28029 Madrid

See on map

Region
Comunidad de Madrid Comunidad de Madrid Madrid
Activity type
Research Organisations
Non-EU contribution
No data

Share this page

Download

EC signature date: 2 February 2021
Last update: 10 June 2022
Record number: 233455

My Booklet

Permalink: https://cordis.europa.eu/project/id/963443

© European Union, 2022